Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

James Burton

Concepts (377)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Liver Transplantation
31
2023
693
3.760
Why?
Hepatitis C
17
2021
218
2.640
Why?
Antiviral Agents
17
2021
635
2.250
Why?
Hepatitis C, Chronic
11
2021
150
2.150
Why?
Ribavirin
8
2015
89
1.460
Why?
Hepacivirus
11
2021
228
0.910
Why?
Proline
6
2015
72
0.890
Why?
Protease Inhibitors
3
2018
96
0.880
Why?
Kidney Transplantation
4
2023
537
0.830
Why?
Liver Function Tests
3
2022
104
0.780
Why?
Liver
10
2023
1630
0.750
Why?
Oligopeptides
5
2015
231
0.720
Why?
Interferon-alpha
3
2014
184
0.710
Why?
Drug Therapy, Combination
12
2018
944
0.680
Why?
Patient Selection
3
2020
625
0.640
Why?
Polyethylene Glycols
4
2014
557
0.630
Why?
Interferons
4
2015
149
0.610
Why?
Graft Rejection
4
2018
508
0.570
Why?
Living Donors
7
2022
270
0.560
Why?
Recurrence
12
2015
925
0.500
Why?
Postoperative Complications
5
2022
2120
0.480
Why?
Liver Failure
3
2016
72
0.480
Why?
Non-alcoholic Fatty Liver Disease
3
2022
244
0.400
Why?
Immunocompromised Host
1
2013
190
0.370
Why?
Viral Nonstructural Proteins
2
2014
54
0.350
Why?
Humans
74
2023
113531
0.340
Why?
Graft Survival
4
2023
441
0.330
Why?
Middle Aged
35
2022
26552
0.330
Why?
Tissue Donors
4
2021
313
0.330
Why?
Home Care Services, Hospital-Based
2
1999
10
0.310
Why?
T-Lymphocytes, Regulatory
2
2008
337
0.310
Why?
Decision Support Techniques
2
2018
336
0.300
Why?
Acute Disease
7
2008
885
0.280
Why?
Esophageal and Gastric Varices
1
2007
30
0.280
Why?
Simeprevir
2
2018
8
0.280
Why?
Severity of Illness Index
5
2021
2530
0.270
Why?
Tissue and Organ Procurement
2
2023
223
0.270
Why?
Health Services for the Aged
5
2000
70
0.260
Why?
Reproducibility of Results
5
2022
2752
0.250
Why?
Liver Cirrhosis
3
2015
226
0.250
Why?
CD4-Positive T-Lymphocytes
2
2008
960
0.250
Why?
United States
17
2023
12137
0.240
Why?
Male
41
2021
55112
0.240
Why?
Geriatrics
7
2000
69
0.240
Why?
Cholates
2
2022
2
0.230
Why?
Health Care Rationing
1
2004
45
0.230
Why?
Aged
29
2018
18944
0.230
Why?
Home Care Services
3
1997
219
0.230
Why?
Treatment Outcome
15
2022
9006
0.220
Why?
Solitary Kidney
1
2023
6
0.220
Why?
Viremia
3
2021
122
0.220
Why?
Cecal Neoplasms
1
2003
1
0.220
Why?
Jejunoileal Bypass
1
2003
1
0.220
Why?
Liver Diseases
1
2006
254
0.220
Why?
Female
39
2021
59115
0.210
Why?
Reoperation
4
2007
505
0.210
Why?
Transplant Recipients
2
2021
130
0.190
Why?
Cholangitis
1
2022
19
0.190
Why?
Forecasting
3
2014
329
0.190
Why?
Recombinant Proteins
4
2014
1214
0.190
Why?
Adult
21
2021
30245
0.180
Why?
Colonoscopy
1
2003
197
0.180
Why?
Cholangitis, Sclerosing
1
2022
66
0.180
Why?
Liver Circulation
1
2021
19
0.180
Why?
Nursing Homes
2
1994
138
0.180
Why?
Carbon Isotopes
1
2021
110
0.180
Why?
Famous Persons
1
2000
6
0.180
Why?
Deuterium
1
2021
79
0.180
Why?
Consensus Development Conferences as Topic
1
2020
28
0.170
Why?
Blood Coagulation Disorders
1
2022
153
0.170
Why?
Healthy Volunteers
1
2021
186
0.170
Why?
Kidney
3
2023
1179
0.170
Why?
Sofosbuvir
2
2021
53
0.170
Why?
Donor Selection
1
2020
65
0.160
Why?
Allografts
1
2020
121
0.160
Why?
Carbamates
2
2021
33
0.160
Why?
Reference Values
1
2021
735
0.160
Why?
Antibiotic Prophylaxis
1
2020
95
0.160
Why?
Coronary Artery Disease
2
2020
610
0.160
Why?
Cohort Studies
6
2018
4880
0.160
Why?
Practice Patterns, Physicians'
2
2005
1176
0.160
Why?
Biopsy
2
2020
1024
0.150
Why?
Physician-Patient Relations
3
2000
459
0.150
Why?
Hepatitis, Autoimmune
1
2018
27
0.150
Why?
RNA, Viral
4
2015
562
0.150
Why?
Geriatric Assessment
2
1997
175
0.150
Why?
Heterocyclic Compounds, 3-Ring
1
2018
28
0.150
Why?
Eligibility Determination
2
1997
59
0.150
Why?
Coronary Angiography
3
2020
307
0.140
Why?
Consensus
1
2020
533
0.140
Why?
Retrospective Studies
11
2022
12504
0.140
Why?
Leukocyte Count
1
2018
291
0.140
Why?
Thrombolytic Therapy
2
1997
117
0.140
Why?
Drug Interactions
3
2013
332
0.140
Why?
Diagnostic Tests, Routine
1
2018
86
0.140
Why?
Forkhead Transcription Factors
2
2008
169
0.140
Why?
End Stage Liver Disease
1
2018
61
0.140
Why?
Adenocarcinoma
1
2003
787
0.140
Why?
HIV Integrase Inhibitors
1
2018
62
0.140
Why?
Family Planning Policy
1
2016
1
0.140
Why?
Odds Ratio
4
2015
953
0.130
Why?
Prognosis
5
2020
3318
0.130
Why?
Health Planning
1
2016
46
0.130
Why?
Public Policy
1
2016
61
0.130
Why?
Prospective Studies
7
2021
6189
0.130
Why?
Long-Term Care
1
2016
77
0.130
Why?
Fibrosis
1
2018
452
0.130
Why?
Population Dynamics
1
2016
122
0.130
Why?
Aortic Valve Insufficiency
1
2015
45
0.120
Why?
Young Adult
7
2021
10400
0.120
Why?
Time Factors
10
2018
6032
0.120
Why?
Genotype
3
2015
1733
0.120
Why?
Macrocyclic Compounds
1
2014
9
0.120
Why?
Developing Countries
1
2016
231
0.120
Why?
Program Evaluation
1
1999
821
0.120
Why?
Survival Analysis
4
2018
1203
0.120
Why?
Anilides
1
2014
67
0.110
Why?
Homes for the Aged
1
1994
19
0.110
Why?
Comprehensive Health Care
1
1994
20
0.110
Why?
Patient Satisfaction
1
1998
570
0.110
Why?
Glucocorticoids
1
2018
520
0.110
Why?
Factor Xa Inhibitors
2
2005
138
0.110
Why?
Transcatheter Aortic Valve Replacement
1
2015
152
0.110
Why?
Follow-Up Studies
6
2016
4384
0.110
Why?
Quality of Life
4
2018
2335
0.100
Why?
Serine Proteinase Inhibitors
1
2013
34
0.100
Why?
Transplantation
1
2013
23
0.100
Why?
Myocardial Infarction
3
2005
932
0.100
Why?
Multivariate Analysis
3
2015
1421
0.100
Why?
Spinal Diseases
1
1993
39
0.100
Why?
Pyridazines
1
2013
46
0.100
Why?
DEAD-box RNA Helicases
1
2013
56
0.100
Why?
Mental Health
1
2018
559
0.100
Why?
Aortic Valve Stenosis
1
2015
266
0.100
Why?
Immunosuppressive Agents
2
2013
633
0.100
Why?
Bile Ducts, Intrahepatic
1
2012
48
0.100
Why?
Cholangiocarcinoma
1
2012
38
0.100
Why?
Bile Duct Neoplasms
1
2012
56
0.100
Why?
Postoperative Care
1
2013
224
0.090
Why?
Interleukins
1
2013
234
0.090
Why?
Hepatic Insufficiency
1
2010
4
0.090
Why?
Chemoradiotherapy
1
2012
187
0.090
Why?
Preoperative Care
1
2013
318
0.090
Why?
Th1 Cells
2
2008
123
0.090
Why?
Blood Component Transfusion
1
2011
63
0.090
Why?
Aged, 80 and over
9
2015
6296
0.090
Why?
Longitudinal Studies
4
2016
2361
0.090
Why?
Primary Health Care
2
1993
1502
0.080
Why?
Death Certificates
1
1990
30
0.080
Why?
Autopsy
1
1990
84
0.080
Why?
Nucleosides
1
2009
25
0.080
Why?
Myocardial Stunning
1
2009
5
0.080
Why?
Erythrocyte Transfusion
1
2011
160
0.080
Why?
Uremia
1
2009
14
0.080
Why?
RNA
1
2015
801
0.080
Why?
Prodrugs
1
2009
42
0.080
Why?
MicroRNAs
1
2015
598
0.080
Why?
Cross Infection
1
2011
195
0.080
Why?
Drug Resistance, Viral
1
2009
99
0.080
Why?
Risk Factors
8
2020
8606
0.080
Why?
Drug Discovery
1
2009
122
0.080
Why?
Vitamin B 12 Deficiency
1
1988
74
0.080
Why?
Biomarkers
2
2015
3389
0.080
Why?
Registries
1
2016
1762
0.080
Why?
Thrombelastography
2
2022
129
0.070
Why?
Predictive Value of Tests
3
2020
1783
0.070
Why?
Interferon-gamma
2
2008
710
0.070
Why?
Urinary Incontinence
1
1988
56
0.070
Why?
Patient Readmission
2
2010
608
0.070
Why?
Acute Lung Injury
1
2011
266
0.070
Why?
Propionates
2
2005
33
0.070
Why?
Ventricular Function, Left
2
2009
469
0.070
Why?
Platelet Count
1
2007
78
0.070
Why?
Naphthalenes
2
2005
37
0.070
Why?
Likelihood Functions
1
2007
123
0.070
Why?
Interleukin-7 Receptor alpha Subunit
1
2006
11
0.070
Why?
Models, Statistical
2
2015
593
0.070
Why?
Receptors, Interleukin-7
1
2006
25
0.070
Why?
Viral Load
2
2021
403
0.070
Why?
Behavior Therapy
1
1988
225
0.070
Why?
ROC Curve
1
2007
442
0.060
Why?
Logistic Models
3
2015
1832
0.060
Why?
Polymorphism, Single Nucleotide
1
2013
1856
0.060
Why?
Renal Dialysis
1
2009
377
0.060
Why?
Proportional Hazards Models
2
2020
1076
0.060
Why?
Heparin
4
2005
225
0.060
Why?
Clinical Trials as Topic
1
2009
922
0.060
Why?
Ambulatory Care
1
1988
480
0.060
Why?
Incidence
2
2010
2310
0.060
Why?
Serine Endopeptidases
1
2005
101
0.060
Why?
Chi-Square Distribution
2
2011
493
0.060
Why?
Treatment Failure
1
2005
323
0.060
Why?
Skilled Nursing Facilities
1
1985
119
0.060
Why?
Kidney Failure, Chronic
1
2009
490
0.060
Why?
House Calls
1
1985
115
0.060
Why?
Reperfusion Injury
1
2006
251
0.050
Why?
Hepatitis B Antibodies
1
2003
10
0.050
Why?
Pilot Projects
3
2009
1356
0.050
Why?
Hepatitis B virus
1
2003
25
0.050
Why?
Endoscopes, Gastrointestinal
1
2003
12
0.050
Why?
Length of Stay
3
2011
963
0.050
Why?
Continuity of Patient Care
1
1985
252
0.050
Why?
Health Care Surveys
1
2005
541
0.050
Why?
Aging
1
1993
1601
0.050
Why?
Risk Assessment
4
2015
2953
0.050
Why?
Sensitivity and Specificity
1
2007
1682
0.050
Why?
Colectomy
1
2003
87
0.050
Why?
Plasma
2
2014
180
0.050
Why?
Choledochostomy
1
2022
11
0.050
Why?
Clinical Protocols
1
2003
231
0.050
Why?
Anastomosis, Roux-en-Y
1
2022
25
0.050
Why?
CD8-Positive T-Lymphocytes
1
2006
686
0.050
Why?
Critical Care
1
1985
474
0.050
Why?
DNA, Viral
1
2003
345
0.050
Why?
Heterocyclic Compounds, 4 or More Rings
1
2021
15
0.050
Why?
Mental Disorders
1
1988
884
0.050
Why?
Referral and Consultation
1
1985
632
0.050
Why?
Proof of Concept Study
1
2021
47
0.050
Why?
Sustained Virologic Response
1
2021
33
0.050
Why?
Thrombosis
1
2004
293
0.040
Why?
Feasibility Studies
2
2004
737
0.040
Why?
Health Planning Councils
1
2000
6
0.040
Why?
Government
1
2000
10
0.040
Why?
Blood Coagulation
1
2022
200
0.040
Why?
Adolescent
6
2015
17724
0.040
Why?
Cholangiopancreatography, Endoscopic Retrograde
1
2022
180
0.040
Why?
Muscular Atrophy
1
2000
74
0.040
Why?
Anticoagulants
1
2004
548
0.040
Why?
Cardiac Surgical Procedures
1
2004
408
0.040
Why?
Baltimore
1
1999
43
0.040
Why?
Specialization
1
2000
112
0.040
Why?
Nephrectomy
1
2020
149
0.040
Why?
History, 20th Century
1
2000
265
0.040
Why?
Drug Administration Schedule
1
2021
712
0.040
Why?
Hospitals, University
1
1999
169
0.040
Why?
General Surgery
1
2000
124
0.040
Why?
Streptokinase
2
1997
10
0.040
Why?
Postoperative Period
2
2016
289
0.040
Why?
Linear Models
1
2021
767
0.040
Why?
Withholding Treatment
1
2018
66
0.040
Why?
Oxazines
1
2018
25
0.040
Why?
Diagnosis-Related Groups
1
1997
27
0.040
Why?
Patient Admission
1
1999
175
0.040
Why?
Safety
1
1999
297
0.040
Why?
Osteoporosis
1
2000
224
0.040
Why?
Area Under Curve
1
2018
271
0.030
Why?
Cause of Death
2
2007
360
0.030
Why?
Pyridones
1
2018
122
0.030
Why?
Tissue Plasminogen Activator
2
1997
204
0.030
Why?
Lymphocytes
1
2018
321
0.030
Why?
Data Collection
1
1999
616
0.030
Why?
Attitude
1
1998
227
0.030
Why?
Myocardial Reperfusion Injury
1
1997
95
0.030
Why?
Fatigue
1
2018
292
0.030
Why?
China
1
2016
161
0.030
Why?
Piperazines
1
2018
309
0.030
Why?
Phlebotomy
1
2015
12
0.030
Why?
Family Characteristics
1
2016
151
0.030
Why?
2-Naphthylamine
1
2014
7
0.030
Why?
Population
1
2015
27
0.030
Why?
Half-Life
1
2015
140
0.030
Why?
Uracil
1
2014
28
0.030
Why?
Cluster Analysis
1
2016
448
0.030
Why?
Social Class
1
2016
203
0.030
Why?
Patient Reported Outcome Measures
1
2017
251
0.030
Why?
Cyclopropanes
1
2014
78
0.030
Why?
North America
1
2015
256
0.030
Why?
Biological Assay
1
2015
112
0.030
Why?
Calcineurin Inhibitors
1
2014
57
0.030
Why?
Lactams, Macrocyclic
1
2014
46
0.030
Why?
Valine
1
2014
72
0.030
Why?
Femoral Artery
1
2015
165
0.030
Why?
Cadaver
1
2015
297
0.030
Why?
Ritonavir
1
2014
69
0.030
Why?
Sex Characteristics
2
2015
633
0.030
Why?
Case-Control Studies
2
2013
2993
0.030
Why?
Frail Elderly
1
1994
106
0.030
Why?
Hepatocytes
1
2014
196
0.030
Why?
Neutrophils
1
2018
1072
0.030
Why?
Leukocytes
1
2014
268
0.030
Why?
DEAD Box Protein 58
1
2013
8
0.030
Why?
Cholestasis
1
2015
227
0.030
Why?
Patient Acceptance of Health Care
1
1998
679
0.020
Why?
HIV-1
1
2018
764
0.020
Why?
Pain
1
2018
699
0.020
Why?
Nitriles
1
2013
149
0.020
Why?
Prevalence
1
2018
2244
0.020
Why?
Receptors, Immunologic
1
2013
195
0.020
Why?
Medicare Part B
1
1991
6
0.020
Why?
Emotions
1
2016
474
0.020
Why?
Physical Examination
1
1993
222
0.020
Why?
Anxiety
1
2018
837
0.020
Why?
Alcoholism
1
2018
704
0.020
Why?
Sulfonamides
1
2014
442
0.020
Why?
Cross-Over Studies
1
2013
432
0.020
Why?
Chromatography, Liquid
1
2013
339
0.020
Why?
Attitude of Health Personnel
1
1998
970
0.020
Why?
Lumbar Vertebrae
1
1993
205
0.020
Why?
Heart Transplantation
1
1997
652
0.020
Why?
Health Services Needs and Demand
1
1992
241
0.020
Why?
Insurance, Health, Reimbursement
1
1991
88
0.020
Why?
Body Weight
1
2015
853
0.020
Why?
Phosphorylation
1
2015
1537
0.020
Why?
Research Design
1
2016
916
0.020
Why?
Tandem Mass Spectrometry
1
2013
405
0.020
Why?
Erythrocytes
1
2015
566
0.020
Why?
Dose-Response Relationship, Drug
2
2005
1822
0.020
Why?
Anti-Retroviral Agents
1
2012
207
0.020
Why?
Neoadjuvant Therapy
1
2012
305
0.020
Why?
Pyrimidines
1
2013
372
0.020
Why?
Obesity
1
2022
2501
0.020
Why?
Depression
1
2018
1131
0.020
Why?
Anemia, Pernicious
1
1988
9
0.020
Why?
Diagnosis, Differential
1
1993
1328
0.020
Why?
Gene Expression Profiling
1
2015
1510
0.020
Why?
Urinary Incontinence, Stress
1
1988
12
0.020
Why?
Biofeedback, Psychology
1
1988
25
0.020
Why?
Fibrinogens, Abnormal
1
2008
4
0.020
Why?
Academic Medical Centers
1
2010
406
0.020
Why?
CD24 Antigen
1
2008
20
0.020
Why?
Vitamin B 12
1
1988
115
0.020
Why?
Societies, Medical
1
1991
654
0.020
Why?
Interleukin-2 Receptor alpha Subunit
1
2008
66
0.020
Why?
Child
2
2021
18340
0.020
Why?
Myocardial Contraction
1
2009
314
0.020
Why?
Hospitalization
1
1996
1765
0.020
Why?
Genes, MHC Class II
1
2007
67
0.020
Why?
Nurse Practitioners
1
1988
95
0.020
Why?
Hospital Mortality
1
2011
780
0.020
Why?
Cytomegalovirus
1
2007
140
0.020
Why?
Stroke Volume
1
2009
510
0.020
Why?
Internal Medicine
1
1988
211
0.020
Why?
Immunity, Cellular
1
2008
246
0.020
Why?
Cross-Sectional Studies
1
2016
4400
0.020
Why?
Organizational Affiliation
1
1985
8
0.020
Why?
Dementia
1
1988
186
0.020
Why?
Waiting Lists
1
2007
204
0.020
Why?
Ultrasonography
1
2009
632
0.020
Why?
Pressure Ulcer
1
1985
31
0.020
Why?
Injections, Intravenous
1
1985
195
0.020
Why?
Partial Thromboplastin Time
1
2005
50
0.020
Why?
Fluid Therapy
1
1985
123
0.010
Why?
Alleles
1
2007
781
0.010
Why?
Genetic Predisposition to Disease
1
2013
2077
0.010
Why?
Pneumonia
1
1990
561
0.010
Why?
Epitopes
1
2006
430
0.010
Why?
Immunologic Memory
1
2006
313
0.010
Why?
International Normalized Ratio
1
2004
42
0.010
Why?
Intraoperative Care
1
2004
34
0.010
Why?
Blood Coagulation Tests
1
2004
51
0.010
Why?
Canada
2
1997
320
0.010
Why?
HIV Infections
1
2018
2440
0.010
Why?
Physician's Role
1
1985
192
0.010
Why?
Flow Cytometry
1
2006
1065
0.010
Why?
Surveys and Questionnaires
1
2014
4593
0.010
Why?
Blood Pressure
1
2009
1521
0.010
Why?
Drug Monitoring
1
2004
184
0.010
Why?
Randomized Controlled Trials as Topic
1
2007
1205
0.010
Why?
Electrocardiography
1
2005
558
0.010
Why?
Ischemia
1
2005
357
0.010
Why?
Colorado
1
2011
4061
0.010
Why?
Hemorrhage
1
2005
599
0.010
Why?
Patient Education as Topic
1
1985
665
0.010
Why?
Models, Biological
1
2007
1589
0.010
Why?
Foundations
1
2000
22
0.010
Why?
Organizational Objectives
1
2000
66
0.010
Why?
Phenotype
1
2006
2754
0.010
Why?
Education, Medical
1
2000
214
0.010
Why?
Vascular Patency
1
1997
96
0.010
Why?
Coronary Circulation
1
1997
131
0.010
Why?
Child, Preschool
1
2009
9093
0.010
Why?
Interviews as Topic
1
1997
574
0.010
Why?
Regression Analysis
1
1997
932
0.010
Why?
Institutionalization
1
1992
12
0.010
Why?
Survival Rate
1
1997
1634
0.010
Why?
Sex Factors
1
1997
1705
0.010
Why?
Organizational Policy
1
1991
67
0.010
Why?
Burton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)